Chrysin Alleviates Monocrotaline-Induced Pulmonary Hypertension in Rats Through Regulation of Intracellular Calcium Homeostasis in Pulmonary Arterial Smooth Muscle Cells

J Cardiovasc Pharmacol. 2020 Jun;75(6):596-602. doi: 10.1097/FJC.0000000000000823.

Abstract

Chrysin (CH) is the main ingredient of many medicinal plants. Our previous study showed that CH could suppress hypoxia-induced pulmonary arterial smooth muscle cells proliferation and alleviate chronic hypoxia-induced pulmonary hypertension by targeting store-operated Ca entry (SOCE)-[Ca]i pathway. In this study, we investigated the effect of CH on monocrotaline-induced pulmonary hypertension (MCTPH) and the mechanism behind it. Results show that, in MCTPH model rats, (1) CH significantly reduced the enhancement of right ventricular pressure, right ventricular hypertrophy, and pulmonary vascular remodeling; (2) CH markedly suppressed the promotion of SOCE and [Ca]i in pulmonary arterial smooth muscle cells; and (3) CH obviously inhibited the MCT-upregulated proliferating cell nuclear antigen, TRPC1, TRPC4, and TRPC6 expression in distal pulmonary arteries. These results demonstrate that CH likely alleviates MCTPH by targeting TRPC1,4,6-SOCE-[Ca]i pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antihypertensive Agents / pharmacology*
  • Arterial Pressure / drug effects*
  • Calcium Signaling / drug effects*
  • Disease Models, Animal
  • Flavonoids / pharmacology*
  • Hypertension, Pulmonary / chemically induced
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / metabolism
  • Hypertension, Pulmonary / physiopathology
  • Hypertrophy, Right Ventricular / chemically induced
  • Hypertrophy, Right Ventricular / metabolism
  • Hypertrophy, Right Ventricular / physiopathology
  • Hypertrophy, Right Ventricular / prevention & control
  • Monocrotaline*
  • Muscle, Smooth, Vascular / drug effects*
  • Muscle, Smooth, Vascular / metabolism
  • Muscle, Smooth, Vascular / physiopathology
  • Pulmonary Artery / drug effects
  • Pulmonary Artery / metabolism
  • Pulmonary Artery / physiopathology
  • Rats, Sprague-Dawley
  • TRPC Cation Channels / antagonists & inhibitors
  • TRPC Cation Channels / metabolism
  • Vascular Remodeling / drug effects*
  • Ventricular Function, Right / drug effects
  • Ventricular Pressure / drug effects
  • Ventricular Remodeling / drug effects

Substances

  • Antihypertensive Agents
  • Flavonoids
  • TRPC Cation Channels
  • TRPC4 ion channel
  • Trpc6 protein, rat
  • transient receptor potential cation channel, subfamily C, member 1
  • chrysin
  • Monocrotaline